Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

First big influenza genome study reveals flu evolution

06.10.2005


Which flu did you get? TIGR scientists survey five New York flu seasons



On the eve of the 2005-06 flu season, scientists at The Institute for Genomic Research (TIGR) have captured influenza evolution in action. In a study published in this week’s journal Nature, the researchers report the first large-scale project to sequence the influenza virus. The study offers a unique snapshot of the rapidly evolving flu virus in a human population--and a new strategy for surveillance.

In the study, TIGR scientists and their colleagues sequenced 209 complete genomes of the human influenza A virus. The genomes represent virus samples, or isolates, taken from patients who visited county clinics across New York over the past five flu seasons, from 1999-2004. Almost all the influenza genomes represent the H3N2 strain, which predominated during these flu seasons. Comparing these genomes, the researchers tracked the changing virus as it moved across the region.


"This study demonstrates that genomics can help us better track the flu virus and develop more effective vaccines," remarks first author Elodie Ghedin, who heads TIGR’s viral genomics lab. "This is perhaps the most detailed snapshot scientists have gotten of flu’s movement through communities."

Across New York State, the researchers documented at least three distinct subpopulations (variants) of the H3N2 influenza virus over the five-year study period. In some of the flu seasons studied, these variants circulated simultaneously. That means New Yorkers weren’t all catching the same flu, but rather slightly different versions of the virus. Even within this relatively small geographic region, Ghedin says, the dynamic influenza virus showed striking diversity, with variants frequently swapping genetic material.

In fact, the researchers report, one such event explains why the 2003-04 flu vaccine offered less protection than usual.

Every flu season, a global network of scientists attempts to identify several predominant flu strains and factor them into the next season’s flu vaccine. Predictions are tricky, however, because influenza is constantly changing. In the 2002-03 flu season, the Nature study reports, a minor H3N2 variant reassorted, or genetically mixed, with the dominant strain. This reassortment yielded a new strain late in the season. The new strain quickly won out, becoming the dominant virus in the 2003-04 flu season. Because scientists had not factored this latecomer strain into the ’03-04 vaccine, however, the vaccine was less effective.

Genomics turns a new spotlight on influenza evolution. By deciphering the genomes of different influenza strains, researchers can pinpoint mutations that allow particular strains to become more virulent, adapt to infect new species, or evade immune response.

Moreover, TIGR’s high-throughput influenza genome sequencing pipeline offers a pivotal strategy for crafting emerging vaccines that work. "Right in the middle of flu season, we could determine which influenza strains are present in the population, which ones are dominant, and how well a given vaccine works," Ghedin notes. She adds that all sequences described in the current study have been deposited in public databases, such as GenBank, which allows immediate access to the scientific community.

The new study represents the initial results from the Influenza Genome Sequencing Project, launched in 2004 by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. As part of this ongoing project, TIGR will sequence thousands of human flu isolates, as well as avian, equine, and swine flu isolates, to recognize influenza’s patterns of genetic change. To do so, TIGR has built an innovative viral genomics lab, which is ramping up to sequence 100 influenza genomes weekly.

Influenza poses a major public health problem. In an ordinary year, the flu kills up to a half million people worldwide. In the U.S., a typical flu season brings 36,000 deaths and 114,000 hospitalizations. Over the past century, three pandemics--in 1918, 1957, and 1968--caused millions of deaths. Today, scientists worry that virulent influenza strains in other species, such as the H5N1 bird flu strain found in poultry and migratory birds in Asia and Russia, will jump the species barrier into humans and trigger a new pandemic.

Although researchers first isolated the influenza virus in 1933, they still don’t fully understand how the virus evolves. Influenza is an RNA virus that contains eight separate RNA segments encoding genes for at least 11 proteins. This structure explains why the influenza virus constantly reassorts genetically. When two different influenza strains infect the same cell, their separate RNA segments can easily swap material, resulting in entirely new strains.

Type A influenzas (one of three major types, or genera) cause widespread flu among humans. Researchers classify type A influenzas according to structural variations in two surface proteins: hemagglutinin (HA) and neuraminidase (NA). Like changing coats, the influenza virus changes the shape of these HA or NA proteins when it accumulates minor mutations or reassorts more dramatically. The human immune system no longer recognizes the virus, and infection begins anew.

Steven Salzberg, senior author of the Nature paper, says the new work illustrates this chain of molecular events. "The study demonstrates that these influenza subpopulations, or variant strains, represent a pool of genetic resources that the influenza virus can draw upon," says Salzberg, a researcher at TIGR and also director of the University of Maryland’s Center for Bioinformatics and Computational Biology. "Pockets of distinct flu strains spread locally, with flu evolving in different directions. Then, when one strain mingles with another, a new, dominant strain can emerge."

Kathryn Brown | EurekAlert!
Further information:
http://www.tigr.org/

More articles from Life Sciences:

nachricht New technology offers fast peptide synthesis
28.02.2017 | Massachusetts Institute of Technology

nachricht Biofuel produced by microalgae
28.02.2017 | Tokyo Institute of Technology

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Safe glide at total engine failure with ELA-inside

On January 15, 2009, Chesley B. Sullenberger was celebrated world-wide: after the two engines had failed due to bird strike, he and his flight crew succeeded after a glide flight with an Airbus A320 in ditching on the Hudson River. All 155 people on board were saved.

On January 15, 2009, Chesley B. Sullenberger was celebrated world-wide: after the two engines had failed due to bird strike, he and his flight crew succeeded...

Im Focus: Breakthrough with a chain of gold atoms

In the field of nanoscience, an international team of physicists with participants from Konstanz has achieved a breakthrough in understanding heat transport

In the field of nanoscience, an international team of physicists with participants from Konstanz has achieved a breakthrough in understanding heat transport

Im Focus: DNA repair: a new letter in the cell alphabet

Results reveal how discoveries may be hidden in scientific “blind spots”

Cells need to repair damaged DNA in our genes to prevent the development of cancer and other diseases. Our cells therefore activate and send “repair-proteins”...

Im Focus: Dresdner scientists print tomorrow’s world

The Fraunhofer IWS Dresden and Technische Universität Dresden inaugurated their jointly operated Center for Additive Manufacturing Dresden (AMCD) with a festive ceremony on February 7, 2017. Scientists from various disciplines perform research on materials, additive manufacturing processes and innovative technologies, which build up components in a layer by layer process. This technology opens up new horizons for component design and combinations of functions. For example during fabrication, electrical conductors and sensors are already able to be additively manufactured into components. They provide information about stress conditions of a product during operation.

The 3D-printing technology, or additive manufacturing as it is often called, has long made the step out of scientific research laboratories into industrial...

Im Focus: Mimicking nature's cellular architectures via 3-D printing

Research offers new level of control over the structure of 3-D printed materials

Nature does amazing things with limited design materials. Grass, for example, can support its own weight, resist strong wind loads, and recover after being...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Booth and panel discussion – The Lindau Nobel Laureate Meetings at the AAAS 2017 Annual Meeting

13.02.2017 | Event News

Complex Loading versus Hidden Reserves

10.02.2017 | Event News

International Conference on Crystal Growth in Freiburg

09.02.2017 | Event News

 
Latest News

Light-emitting bubbles captured in the wild

28.02.2017 | Physics and Astronomy

Triboelectric nanogenerators boost mass spectrometry performance

28.02.2017 | Materials Sciences

Calculating recharge of groundwater more precisely

28.02.2017 | Ecology, The Environment and Conservation

VideoLinks
B2B-VideoLinks
More VideoLinks >>>